马航

发布时间:2022-09-09 09:41:18 作者: 浏览次数: 次

 

个人简介

马航,男,19936月出生,医学博士,副教授。主要从事天然产物的药理、药效研究;哺乳动物及原核生物的生理机制和功能的发现及探索;蛋白大分子的结构和功能研究。

 

教育及工作经历

2022/07-至今,西南大学,药学院,副教授

2018/09-2022/06,上海交通大学,微生物与生化药学,博士

2015/09-2018/06,西南大学,中药学,硕士

2011/09-2015/06,重庆大学,制药工程,学士

 

联系方式

hangma@swu.edu.cn

 

主要代表论文

1. Hang Ma1, Yingying Guo1, Haoneng Tang1, et al., Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD. Cell Discovery, 8:16, 2022.

2. Hang Ma, Yang Yu, Meimei Wang, et al., Correlation between microbes and colorectal cancer: tumor apoptosis is induced by sitosterols through promoting gut microbiota to produce short-chain fatty acids. Apoptosis, 24:168–183, 2019.

3. Hang Ma1, Kai He1, Jianwei Zhu, et al., The anti-hyperglycemia effects of Rhizoma Coptidis alkaloids: A systematic review of modern pharmacological studies of the traditional herbal medicine. Fitoterapia, 134:210–220, 2019.

4. Hang Ma, Yinran Hu, Zongyao Zou, et al., Antihyperglycemia and Antihyperlipidemia Effect of Protoberberine Alkaloids From Rhizoma Coptidis in HepG2 Cell and Diabetic KK-Ay Mice. Drug Development Research, 77:163–170, 2016.